Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address the unmet clinical need in chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other hematologic malignancies.
Symbol:APS
Company Name:Aptose Biosciences Inc.
Price: $3.55
Previous Close:$3.64
Open Price$3.61
Daily High$3.71
Daily Low$3.54
Market Cap:242799947
Currency:CAD
Change Percentage: -2.47%
Last Traded Date:Monday, September 13, 2021 3:43 PM
Volume:60967
52 Week High:$9.40
52 Week Low:$3.01
EPS:$-0.83
PE:No Data
Volume Average:33850
Stock Exchange:Toronto Stock Exchange